Approxima is an early-stage MedTech startup that is creating a percutaneous tricuspid valve replacement method.
Approxima has raised $7.7M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Approxima's investors include Panakes Partners, Club degli Investitori, ENEA Tech e Biomedical.
Approxima is headquartered in Milan, Italy.
Approxima is an early-stage MedTech startup that is creating a percutaneous tricuspid valve replacement method.
Approxima is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Approxima — Funding & Investors." VCBacked, February 20, 2025, https://www.vcbacked.co/company/approxima. Accessed September 30, 2026.
VCBacked. (2025). Approxima — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/approxima
{{cite web |title=Approxima — Funding & Investors |url=https://www.vcbacked.co/company/approxima |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated